Vanguard Group Inc Cassava Sciences Inc Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,170,072 shares of SAVA stock, worth $4.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,170,072
Previous 2,442,307 11.15%
Holding current value
$4.51 Million
Previous $3.66 Million 7.21%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$1.19 - $2.24 $323,959 - $609,806
-272,235 Reduced 11.15%
2,170,072 $3.93 Million
Q1 2025

May 09, 2025
SELL
$1.5 - $3.02 $106,767 - $214,957
-71,178 Reduced 2.83%
2,442,307 $3.66 Million
Q4 2024

Feb 11, 2025
SELL
$2.29 - $32.18 $21,326 - $299,692
-9,313 Reduced 0.37%
2,513,485 $5.93 Million
Q3 2024

Nov 13, 2024
SELL
$9.57 - $35.08 $1.53 Million - $5.62 Million
-160,328 Reduced 5.98%
2,522,798 $74.2 Million
Q2 2024

Aug 13, 2024
BUY
$12.35 - $26.11 $4.03 Million - $8.53 Million
326,646 Added 13.86%
2,683,126 $33.1 Million
Q1 2024

May 10, 2024
BUY
$18.44 - $26.41 $587,387 - $841,264
31,854 Added 1.37%
2,356,480 $47.8 Million
Q4 2023

Feb 14, 2024
BUY
$12.64 - $30.11 $708,598 - $1.69 Million
56,060 Added 2.47%
2,324,626 $52.3 Million
Q3 2023

Nov 14, 2023
BUY
$16.64 - $25.32 $314,612 - $478,725
18,907 Added 0.84%
2,268,566 $37.7 Million
Q2 2023

Aug 14, 2023
BUY
$21.59 - $27.88 $275,358 - $355,581
12,754 Added 0.57%
2,249,659 $55.2 Million
Q1 2023

May 15, 2023
BUY
$23.46 - $36.44 $937,930 - $1.46 Million
39,980 Added 1.82%
2,236,905 $54 Million
Q4 2022

Feb 10, 2023
BUY
$27.82 - $44.16 $2.42 Million - $3.84 Million
87,062 Added 4.13%
2,196,925 $64.9 Million
Q3 2022

Nov 14, 2022
BUY
$16.33 - $51.06 $1.01 Million - $3.17 Million
62,151 Added 3.04%
2,109,863 $88.2 Million
Q2 2022

Aug 12, 2022
BUY
$17.22 - $38.47 $1.26 Million - $2.81 Million
72,983 Added 3.7%
2,047,712 $57.6 Million
Q1 2022

May 13, 2022
SELL
$32.6 - $53.05 $2.81 Million - $4.57 Million
-86,090 Reduced 4.18%
1,974,729 $73.3 Million
Q4 2021

Feb 14, 2022
BUY
$36.77 - $90.91 $3.18 Million - $7.87 Million
86,537 Added 4.38%
2,060,819 $90.1 Million
Q3 2021

Nov 12, 2021
BUY
$41.79 - $135.3 $6.19 Million - $20 Million
148,079 Added 8.11%
1,974,282 $123 Million
Q2 2021

Aug 13, 2021
BUY
$32.15 - $89.72 $58.7 Million - $164 Million
1,826,203 New
1,826,203 $156 Million

Others Institutions Holding SAVA

# of Institutions
131
Shares Held
14.2M
Call Options Held
962K
Put Options Held
864K
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $83.4M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email